Zydus Lifesciences ropes in Tushar Shroff as President-Finance

Gujarat: Zydus Lifesciences has announced the appointment of Tushar Shroff as a President-Finance.”This is to inform that based on the recommendation of Nomination and Remuneration
Committee, the Board of Directors of Zydus Lifesciences Limited have approved the
appointment of Mr. Tushar Shroff as a President-Finance, who shall form part of the Senior
Management Personnel,” Zydus informed in a BSE filing.Tushar Shroff, aged 55 years, is a Chartered
Accountant and a Cost Accountant.
He has 29+ years’ post qualification experience, out
of which 20 years’ experience is in pharma industry.
In pharma industry, he has experience in managing
pharmaceutical life cycle of small, large molecules,
blood products, from innovation to late life cycle
development of generic, branded generic, CDMO
and OTC business for USA, EU, and pharma emerging
markets.
Out of 29 years, he has 15+ years’ experience as a
chief financial officer. He has domain knowledge in
the areas of business partnering, operational
finance, corporate finance, mergers and acquisitions,
divestures, in / out licensing, treasury management
and fund raising, investor relations, strategic finance (structuring and re-organisation), legal, secretarial
and information technology.
Amongst others, he has worked with ABB Limited,
Piramal Healthcare Limited and IntasPharmaceuticals Limited. He had also worked with
Zydus Lifesciences Limited from December 2010 to
January 2019. Before joining Zydus, he was the Chief
Financial Officer at Sterlite Technologies Limited.
Read also: Zydus Lifesciences inks pact with PAI Partners, other shareholders to buy majority stake in Amplitude Surgical SAZydus Lifesciences Ltd. is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs.
Read also: Zydus Medtech, Braile Biomedica of Brazil ink global licensing pact to commercialise TAVI technology